MustGrow Biologics 

C$1.49
13
+C$0.03+2.05% 今天

统计数据

当日最高
-
当日最低
-
52周最高
-
52周最低
-
成交量
-
平均成交量
-
市值
76.94M
市盈率
0
股息收益率
-
股息
-

即将到来

收益

27Nov预期
Q1 2022
Q2 2022
Q3 2022
Q3 2023
Q1 2024
Q2 2024
下一个
-0.04
-0.03
-0.02
-0.01
预期每股收益
-0.04079615124
实际每股收益
N/A

人们还关注

此列表基于关注MGRO.V的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
Show more...
首席执行官
Mr. Corey J. Giasson B.Sc., MBA
国家
CA
ISIN
CA62822A1030

上市公司